calcitonin (Watson Laboratories)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecalcitonin (Watson Laboratories)
Drug Alias Namecalcitonintransmucosal calcitonin (TheraTech)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCalcitonin receptor agonists
TargetsCalcitonin receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWatson Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWatson Laboratories Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A